(S (NP (NP (DT A) (JJ major) (NN barrier)) (PP (PP (IN to) (NP (NML (JJ medical) (NN imaging)) (NN research))) (CC and) (PP (IN in) (NP (NP (JJ particular) (DT the) (NN development)) (PP (IN of) (NP (JJ artificial) (NN intelligence) (PRN (-LRB- -LRB-) (NP (NN AI)) (-RRB- -RRB-)))))))) (VP (VBZ is) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (NP (JJ large) (NNS databases)) (PP (IN of) (NP (NP (JJ medical) (NNS images)) (SBAR (WHNP (WDT which)) (S (VP (VBP share) (NP (NNS images)) (PP (IN with) (NP (JJ other) (NNS researchers)))))))))))) (. .))
(S (S (PP (IN Without) (NP (JJ such) (NNS databases))) (NP (PRP it)) (VP (VBZ is) (RB not) (ADJP (JJ possible) (S (VP (TO to) (VP (VB train) (NP (JJ generalisable) (NN AI) (NNS algorithms)))))))) (, ,) (CC and) (S (NP (NP (JJ large) (NNS amounts)) (PP (IN of) (NP (NN time) (CC and) (NN funding)))) (VP (VBZ is) (VP (VBN spent) (S (VP (VBG collecting) (NP (JJR smaller) (NNS datasets)) (PP (IN at) (NP (JJ individual) (NN research) (NNS centres)))))))) (. .))
(S (NP (NP (DT The) (NNP OPTIMAM) (NN image) (NN database)) (-LRB- -LRB-) (NP (NNP OMI) (HYPH -) (NNP DB)) (-RRB- -RRB-)) (VP (VBZ has) (VP (VBN been) (VP (VBN developed) (S (VP (TO to) (VP (VB overcome) (NP (DT these) (NNS barriers)))))))) (. .))
(S (NP (NNP OMI) (HYPH -) (NNP DB)) (VP (VBZ consists) (PP (IN of) (NP (NP (JJ several) (JJ relational) (NNS databases)) (CC and) (NP (NML (NN cloud) (NN storage)) (NNS systems)))) (, ,) (S (VP (VBG containing) (NP (NP (NN mammography) (NNS images)) (CC and) (NP (VBN associated) (ADJP (JJ clinical) (CC and) (JJ pathological)) (NN information)))))) (. .))
(S (NP (DT The) (NN database)) (VP (VBZ contains) (PP (IN over) (NP (QP (CD 2.5) (CD million)) (NNS images))) (PP (IN from) (NP (NP (CD 173,319) (NNS women)) (VP (VBN collected) (PP (IN from) (NP (CD three) (NNP UK) (NN breast) (NN screening) (NNS centres))))))) (. .))
(S (NP (DT This)) (VP (VBZ includes) (NP (NP (NP (CD 154,832) (NNS women)) (PP (IN with) (NP (JJ normal) (NNS breasts)))) (, ,) (NP (NP (CD 6909) (NNS women)) (PP (IN with) (NP (JJ benign) (NNS findings)))) (, ,) (NP (ADJP (NP (NP (CD 9690) (NNS women)) (PP (IN with) (NP (NN screen)))) (HYPH -) (VBN detected)) (NNS cancers)) (CC and) (NP (NP (CD 1888) (NNS women)) (PP (IN with) (NP (NN interval) (NNS cancers)))))) (. .))
(S (NP (NNP Collection)) (VP (VBZ is) (UCP (SBAR (IN on) (HYPH -) (FRAG (S (VP (VBG going))))) (CC and) (NP (NP (NP (DT all) (NNS women)) (SBAR (S (VP (VBP are) (VP (VBN followed) (PRT (HYPH -) (RP up))))))) (CC and) (NP (NP (PRP$ their) (JJ clinical) (NN status)) (VP (VBN updated) (PP (VBG according) (PP (IN to) (NP (JJ subsequent) (NN screening) (NNS episodes))))))))) (. .))
(S (NP (NP (DT The) (NN availability)) (PP (IN of) (NP (NP (JJ prior) (NN screening) (NNS mammograms)) (CC and) (NP (NN interval) (NNS cancers))))) (VP (VBZ is) (NP (NP (DT a) (JJ vital) (NN resource)) (PP (IN for) (NP (NN AI) (NN development))))) (. .))
(S (NP (NP (NNS Data)) (PP (IN from) (NP (NNP OMI) (HYPH -) (NNP DB)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shared) (PP (IN with) (NP (NP (QP (IN over) (CD 30)) (NN research) (NNS groups) (CC and) (NNS companies)) (, ,) (PP (IN since) (NP (CD 2014)))))))) (. .))
(S (NP (DT This) (JJ progressive) (NN approach)) (VP (VP (VBZ has) (VP (VBN been) (ADJP (JJ possible) (PP (IN through) (S (VP (VBG sharing) (NP (NP (NNS agreements)) (PP (IN between) (NP (DT the) (NN funder)))))))))) (CC and) (VP (VBD approved) (NP (UCP (JJ academic) (CC and) (JJ commercial)) (NN research) (NNS groups)))) (. .))
(S (NP (NP (DT A) (NN research) (NN dataset)) (PP (JJ such) (IN as) (NP (DT the) (NML (NNP OMI) (HYPH -) (NNP DB))))) (VP (VBZ provides) (NP (NP (DT a) (JJ powerful) (NN resource)) (PP (IN for) (NP (NN research))))) (. .))
